News headlines about Express Scripts (NASDAQ:ESRX) have trended positive on Saturday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Express Scripts earned a media sentiment score of 0.28 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.5499701041337 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news stories that may have effected Accern’s scoring:
- Jefferies Group Reiterates $80.00 Price Target for Express Scripts (ESRX) (americanbankingnews.com)
- You can’t brush off the outlook: Express Scripts Holding Company (ESRX), Qudian Inc. (QD) – Market Movers (financialqz.com)
- Express Scripts (ESRX) Receives Hold Rating from Royal Bank of Canada (americanbankingnews.com)
- Express Scripts (ESRX) PT Set at $82.00 by SunTrust Banks (americanbankingnews.com)
- UPDATE 1-Express Scripts forecast 2018 profit above estimates, shares rise (ESRX) (markets.businessinsider.com)
A number of brokerages have recently issued reports on ESRX. Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a report on Friday. Mizuho set a $67.00 target price on Express Scripts and gave the stock a “hold” rating in a report on Tuesday, October 24th. Robert W. Baird raised Express Scripts from a “neutral” rating to an “outperform” rating and raised their price target for the company from $72.00 to $81.00 in a report on Friday. SunTrust Banks set a $82.00 price target on Express Scripts and gave the company a “buy” rating in a report on Thursday. Finally, Jefferies Group set a $80.00 price target on Express Scripts and gave the company a “buy” rating in a report on Friday. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Express Scripts presently has a consensus rating of “Hold” and an average target price of $74.40.
Shares of Express Scripts (NASDAQ:ESRX) traded up $2.53 on Friday, reaching $71.55. The company’s stock had a trading volume of 8,786,136 shares, compared to its average volume of 4,094,484. The company has a market cap of $39,091.06, a price-to-earnings ratio of 10.09, a price-to-earnings-growth ratio of 1.02 and a beta of 0.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts has a 52-week low of $55.80 and a 52-week high of $73.42.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the company earned $1.74 EPS. equities analysts forecast that Express Scripts will post 7.01 earnings per share for the current fiscal year.
In related news, CEO Timothy C. Wentworth purchased 8,000 shares of Express Scripts stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Phyllis S. Anderson sold 643 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by company insiders.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.